Schrödinger (SDGR) Stock Price, News & Analysis

Company Overview

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Key Stats

• Today's Range: $25.61 to $27.00
• 50-Day Range: $17.97 to $26.54
• 52-Week Range: $16.60 to $28.47
• Volume: 832,106 shs
• Average Volume: 835,914 shs
• Market Capitalization: $1.93 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $33.00
• Consensus Rating: Buy

Schrödinger Stock Analysis - MarketRank™

Schrödinger scored higher than 32% of companies evaluated by MarketBeat, and ranked 442nd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Buy

Consensus Rating

Schrödinger has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Schrödinger has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Schrödinger are expected to grow in the coming year, from ($2.37) to ($2.08) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Schrödinger is -11.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Schrödinger is -11.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Schrödinger has a P/B Ratio of 3.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

14.03% of the float of Schrödinger has been sold short.

Short Interest Ratio / Days to Cover

Schrödinger has a short interest ratio ("days to cover") of 9.2.

Change versus previous month

Short interest in Schrödinger has recently increased by 5.06%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Schrödinger does not currently pay a dividend.

Dividend Growth

Schrödinger does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

14.03% of the float of Schrödinger has been sold short.

Short Interest Ratio / Days to Cover

Schrödinger has a short interest ratio ("days to cover") of 9.2.

Change versus previous month

Short interest in Schrödinger has recently increased by 5.06%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.92

News Sentiment

Schrödinger has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Schrödinger this week, compared to 4 articles on an average week.

Search Interest

Only 5 people have searched for SDGR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

4 people have added Schrödinger to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Schrödinger insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $539,064.00 in company stock.

Percentage Held by Insiders

Only 8.60% of the stock of Schrödinger is held by insiders.

Percentage Held by Institutions

79.05% of the stock of Schrödinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SDGR Stock Analysis - Frequently Asked Questions

How have SDGR shares performed this year?

Schrödinger's stock was trading at $19.29 at the beginning of the year. Since then, SDGR stock has increased by 37.1% and is now trading at $26.45.
View the best growth stocks for 2025 here.

How were Schrödinger's earnings last quarter?

Schrödinger, Inc. (NASDAQ:SDGR) posted its quarterly earnings data on Wednesday, February, 26th. The company reported ($0.55) earnings per share for the quarter, missing analysts' consensus estimates of ($0.35) by $0.20. The firm had revenue of $88.32 million for the quarter, compared to analysts' expectations of $83.20 million. Schrödinger had a negative trailing twelve-month return on equity of 35.77% and a negative net margin of 91.84%.
Read the conference call transcript.

When did Schrödinger IPO?

Schrödinger (SDGR) raised $150 million in an initial public offering (IPO) on Thursday, February 6th 2020. The company issued 10,000,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets served as the underwriters for the IPO.

Who are Schrödinger's major shareholders?

Top institutional investors of Schrödinger include Sumitomo Mitsui Trust Group Inc. (4.74%), Stanley Laman Group Ltd. (0.26%), Allspring Global Investments Holdings LLC (0.24%) and GAMMA Investing LLC (0.17%). Insiders that own company stock include Ramy Farid, Kenneth Patrick Lorton, Geoffrey Craig Porges, Karen Akinsanya, Margaret Dugan, Yvonne Tran, Jenny Herman, Robert Lorne Abel and Nancy Thornberry.
View institutional ownership trends.

How do I buy shares of Schrödinger?

Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Schrödinger own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Schrödinger investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 2/26/2025
• Today: 4/26/2025
• Next Earnings (Estimated): 4/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SDGR
• CIK: 1490978
• Web: www.schrodinger.com
• Phone: 212-295-5800
• Fax: N/A
• Employees: 790
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $33.00
• High Stock Price Target: $45.00
• Low Stock Price Target: $28.00
• Potential Upside/Downside: +24.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 8 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($2.57)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $40.72 million
• Net Margins: -91.84%
• Pretax Margin: -92.05%
• Return on Equity: -35.77%
• Return on Assets: -24.51%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.11
• Quick Ratio: 4.11

Sales & Book Value

• Annual Sales: $207.54 million
• Price / Sales: 9.31
• Cash Flow: $0.71 per share
• Price / Cash Flow: 37.42
• Book Value: $7.60 per share
• Price / Book: 3.48

Miscellaneous

• Outstanding Shares: 73,038,000
• Free Float: 66,593,000
• Market Cap: $1.93 billion
• Optionable: Optionable
• Beta: 1.77